If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarrs Group Regulatory News (CARR)

Share Price Information for Carrs Group (CARR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 131.00
Bid: 131.50
Ask: 133.50
Change: -1.00 (-0.76%)
Spread: 2.00 (1.521%)
Open: 131.00
High: 132.00
Low: 130.00
Prev. Close: 132.00
CARR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Carr's Group acquires NuVision Engineering, Inc.

7 Aug 2017 07:00

RNS Number : 1620N
Carr's Group PLC
07 August 2017
 

7 August 2017

 

 

 

Carr's Group plc

"Carr's" or the "Group"

 

Carr's Group acquires NuVision Engineering, Inc.

 

 

7 August: Carr's Group plc, the Agriculture and Engineering group, is pleased to announce it has acquired 100% of ESI Holding Company, Inc., the holding company of USA based engineering company NuVision Engineering, Inc. ("NuVision"), for an initial cash consideration of $11.5m (£8.8m) and a total cash consideration of up to $20m (£15.4m) dependent on future financial performance. The initial consideration will be financed through a combination of new and existing debt facilities, and the contingent consideration will be financed from NuVision's future retained earnings.

 

NuVision, founded in 1971 and headquartered in Pittsburgh, Pennsylvania with operations in Charlotte, North Carolina, is a leading technology and applications engineering company focussed on providing value in commercial nuclear and power plant facilities, government waste remediation facilities and waste clean-up. Its customers include the USA Department of Energy, major nuclear energy suppliers, public utilities, and international governments. NuVision is also a 49% minority shareholder in Mid Columbia Engineering, Inc. ("MCE"), an engineering company based in Richland, Washington and local to the Hanford Site nuclear complex.

 

NuVision's specialist technologies and activities undertaken include:

 

· MSIP®: a patented technology to improve nuclear safety and prolong operational life through crack

mitigation in power plant welds;

· Power Fluidics™: maintenance free systems for mixing, sampling, and retrieving

hazardous/radioactive liquids, slurries and sludge;

· Decontamination: efficient and effective systems for decontaminating pipe-ends and other artefacts

in nuclear power plants during standard maintenance procedures;

· Robotics: a suite of heavy duty manipulators for use in clean-up operations, complementing the range

currently offered by the Group's existing remote handling operations; and

· R&D consultancy: working with the USA Department of Energy to develop innovative solutions for the

nuclear industry.

 

Strategic rationale

 

The acquisition provides a strong foothold into the main nuclear markets in the USA and will enable revenue synergies with the Group's existing nuclear engineering businesses, including the opportunity to market Wälischmiller's products in the USA. It will also extend the Group's service capability in the nuclear market due to the complementary nature of NuVision's product range. NuVision will also act as a key supplier under a major nuclear contract signed on 20 July 2017 and being delivered by our UK Manufacturing business in the next financial year.

 

It is in line with the Group's stated strategy of growing our international footprint, focussing on growth markets with significant potential and to be at the forefront of innovation and technology.

 

 

Highlights of the acquisition

 

· USA presence for the wider engineering division providing access into the main nuclear markets in the USA

· Provide the group with specialised IP

· Extensive contract and opportunity pipeline

· Innovative technology

· Revenue synergies with Bendalls / Wälischmiller and complementary products to our existing manipulator business

· Experienced senior management team to remain with the business, integrating their knowledge and relationships in the USA nuclear market into the existing engineering division

 

 

For the year ended 31 March 2017, the company generated revenue of $8.8m and proforma EBITDA and profit before tax adjusted to exclude non-recurring items and amortisation of intangibles was $2.3m and $1.1m. Reported profit before tax for the year was $0.2m (after non-recurring items of $0.6m, amortisation of intangible assets of $0.3m, and depreciation of revalued assets of $0.8m), and gross assets at 31 March 2017 were $12.5m.

 

Total consideration is up to a maximum of $20m, on a cash/debt free basis, with an initial consideration payable in cash of $11.5m (before adjustments for working capital and net debt). The remaining $8.5m will be payable in cash contingent on delivering a certain level of EBITDA performance post acquisition over the 32 month period to 31 March 2020. The initial consideration is being funded through £6m of new term loan facilities, and use of the Group's existing undrawn revolving credit facilities.

 

Commenting on the acquisition, Tim Davies, CEO, said:

 

"I am delighted to announce the acquisition of NuVision Engineering, Inc. This acquisition lays the foundations for growth into the USA and wider international nuclear markets and provides us with access to specialised IP and a strong pipeline of long term contract opportunities. Additionally, this presents a significant opportunity for us to expand our existing remote handling operations into the USA market.

 

"The management team at NuVision have created long lasting and sustained relationships with a number of major nuclear customers and we look forward to building on this and continuing to invest in the business and the team."

 

Also commenting on the acquisition, Van Walker, President and CEO of NuVision, said:

 

"I am very excited about the prospect of NuVision Engineering becoming part of Carr's Group. The acquisition will enable the two companies to work seamlessly in providing value adding engineering services to the USA and wider global nuclear markets."

 

 

Enquiries:

 

Carr's Group plcTim Davies (Chief Executive)Neil Austin (Group Finance Director)

Tel: +44 (0) 1228 554 600

 

 

PowerscourtNick Dibden / Lisa Kavanagh

Tel: +44 (0) 20 7250 1446

 

 

About Carr's Group plc:

 

Carr's is an international leader in manufacturing value added products and solutions, with market leading brands and robust market positions in Agriculture and Engineering, supplying customers in 35 countries around the world.

 

Its Agriculture division manufactures and supplies feed blocks for livestock, farm machinery and runs a UK network of rural stores, providing a one-stop shop for the farming community. Its Engineering division designs and manufactures bespoke equipment for use in the nuclear, petrochemical, oil and gas, pharmaceutical, process and renewable energy industries, including robotic and remote handling equipment.

 

Nothing in this announcement is intended to be a profit forecast and this statement should not be interpreted to mean that the future profitability of the Group will necessarily match or exceed the historical published earnings of either Carr's or NuVision.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQLLFLITFISIID
Date   Source Headline
8th May 20242:24 pmRNSTotal Voting Rights
24th Apr 202410:31 amRNSReplacement: Strategic Update and Interim Results
18th Apr 20247:00 amRNSStrategic Update and Interim Results
15th Apr 202411:45 amRNSAppointment of Joint Corporate Broker
9th Apr 20247:00 amRNSTotal Voting Rights
7th Mar 202412:57 pmRNSTotal Voting Rights
22nd Feb 202412:40 pmRNSTotal Voting Rights
21st Feb 20242:58 pmRNSResult of Annual General Meeting 2024
31st Jan 20241:36 pmRNSBlocklisting Application
29th Jan 20249:48 amRNSDirector/PDMR Shareholding
24th Jan 20247:00 amRNSDirector/PDMR Shareholding
24th Jan 20247:00 amRNSDirector/PDMR Shareholding
16th Jan 202410:15 amRNSHolding(s) in Company
15th Jan 20243:13 pmRNSHolding(s) in Company
10th Jan 20245:29 pmRNSNotice of AGM 2024 and 2023 Annual Report
9th Jan 202412:43 pmRNSHolding(s) in Company
2nd Jan 20247:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
2nd Jan 20247:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
27th Dec 20237:22 amRNSPublication of Annual Report and Accounts 2023
21st Dec 20237:00 amRNSFull Year Results
13th Dec 20231:03 pmRNSNotice of Results
13th Nov 20237:00 amRNSLeadership Changes and Notice of Results
1st Nov 20233:22 pmRNSOutcome of Shareholder Engagement
16th Oct 20232:13 pmRNSHolding(s) in Company
10th Oct 20237:00 amRNSTrading Update
6th Oct 20234:09 pmRNSNon-Executive Director Succession
2nd Oct 20239:44 amRNSHolding(s) in Company
31st Aug 20239:52 amRNSTotal Voting Rights
16th Aug 20234:24 pmRNSDirector/PDMR Shareholding
7th Aug 20237:00 amRNSCEO succession
4th Aug 20237:00 amRNSTrading Update
18th Jul 20239:07 amRNSHolding(s) in Company
7th Jul 20239:50 amRNSDirector/PDMR Shareholding
6th Jul 202312:40 pmRNSBLOCK LISTING SIX MONTHLY RETURN
6th Jul 202312:39 pmRNSBLOCK LISTING SIX MONTHLY RETURN
4th Jul 20234:48 pmRNSDirector/PDMR Shareholding
30th Jun 20239:44 amRNSTotal Voting Rights
13th Jun 202312:11 pmRNSHolding(s) in Company
31st May 20234:50 pmRNSTotal Voting Rights
23rd May 20231:01 pmRNSHolding(s) in Company
19th May 202312:57 pmRNSDirector/PDMR Shareholding
16th May 20231:32 pmRNSDirector/PDMR Shareholding
16th May 20239:20 amRNSDirector/PDMR Shareholding
5th May 20231:26 pmRNSDirector/PDMR Shareholding
5th May 20239:23 amRNSDirector/PDMR Shareholding
5th May 20239:22 amRNSDirector/PDMR Shareholding
4th May 20236:00 pmRNSReplacement: Holding(s) in Company
2nd May 20235:36 pmRNSReplacement: Total Voting Rights
2nd May 20233:09 pmRNSResult of General Meeting 2 May 2023
2nd May 202312:41 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.